About
Basic Data Updated:
2 months agoThe Corporate was formerly known as Time Cap Pharma Labs Pvt Ltd. The Company is engaged in the Chemicals And Resources Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 cr and a paid-up capital of Rs 0.42 cr.
The Corporate currently has active open charges totaling ₹3.08 cr.
Anand Tummala, Sadasiva Nannapaneni, and Adinarayana Madineedi serve as directors at the Company.
Industry
Company Details
- LocationHyderabad, Telangana
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24232TG1988PTC008333 |
| Company No. | 008333 |
| Company Classification | Private Limited Indian Non-Government Company |
| Incorporation Date | 19 Feb 1988 |
| Date of AGM | 29 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Hyderabad |
Financials of Time Cap Pharma Labs Private Limited
Corporate Structure
Unlock access to Time Cap Pharma Labs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Time Cap Pharma Labs Private Limited
Unlock and access historical data on people associated with Time Cap Pharma Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Board Members(3)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Oriental Bank Of Commerce Creation Date: 09 Dec 1994 | ₹1.40 Cr | Open |
Oriental Bank Of Commerce Creation Date: 28 Dec 1992 | ₹1.68 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Time Cap Pharma Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Time Cap Pharma Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Natco Drug Discovery Private Limited
Active
35 years 4 months Sadasiva Nannapaneni is a mutual person
Natsoft Information Systems Private Limited
Active 26 years 2 months Sadasiva Nannapaneni is a mutual person
Recent activity within the organization
Annual General Meeting
Time Cap Pharma Labs Private Limited last Annual general meeting of members was held on 29 Sep 2023 as per latest MCA records.
29 Sep 2023Balance Sheet
Time Cap Pharma Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
31 Mar 2023Director Appointment
Adinarayana Madineedi was appointed as a Director was appointed as a Director on 31 Jan 2019 & has been associated with this company since 5 years 7 months .
31 Jan 2019Director Appointment
Sadasiva Rao Nannapaneni was appointed as a Director was appointed as a Director on 30 Apr 2009 & has been associated with this company since 15 years 4 months .
30 Apr 2009Director Appointment
Anand Babu Tummala was appointed as a Director was appointed as a Director on 29 Apr 2000 & has been associated with this company since 24 years 4 months .
29 Apr 2000
Recent News, Updates & Announcement
Natco Pharma to acquire 5 stake in biotech startup Cellogen Therapeutics for 15 cr.The Hindu 17 Jan 2024
- Natco Pharma seeks US FDA nod for copy of cancer drug facing lawsuit.
The Hindu 27 Jul 2023
- Natco Pharma launches generic hepatitis C drug in India.
The company has launched a generic version of sofosbuvir 400 mgvelpatasvir 100 mg fixed dose combination in India under the brand name Velpanat.
Economic Times 07 Mar 2023
- Natcos partner Alvogen gets nod for influenza drug in US.
In December last year Alvogen launched the first generic equivalent to oseltamivir phosphate capsules in the United States.
PTI 03 Nov 2017
- Natco Pharmas Generic Tamiflu Deal Brings in Big Profits in Q3 Shares Soar.
When you sell generic Tamiflu in the US and make bank Natco Pharmas net profit rose to Rs 1948 crore in Q3 thanks to the exclusivity of their generic Tamiflu drug They made a deal with Gilead and Roche and teamed up with Alvogen Inc to challenge patents Tamiflu had US sales of 403 million in 2015 Natcos shares went up while Sensex went down.
Moneycontrol 14 Feb 2017
Frequently asked questions
What is the Incorporation or founding date of Time Cap Pharma Labs Private Limited?
